News items included are:-
Football Managers Unite to give Life-Savings team talks for PCUK
Survey shows Half of UK GPs are Unwaware of Black Men's Increased Risk
Alan Pardew on how Prostate Cancer has affected his family
To see the full newsletter click here (http://email.prostatecanceruk.org/q/1m8uJeI9vH1IFa1jp2ws/wv)
This month, we've had another stark reminder of how it's not just men that are unaware of the risks of prostate cancer, but health professionals too. Our new survey of GPs across the UK showed almost half didn't know about black men's increased risk of the disease – so we're doing something about it. We've also got news of a how an ovarian cancer drug could help many more men with prostate cancer, and we look at the long-distance surgery in Northern Ireland that's causing great distress for some men.
Tackle has been asked to contact their members about the opportunity to participate in two surveys. Tackle always look carefully at the many requests we receive to engage with our member groups. These two are of particular interest, one from Prostate Cancer UK and one from Edinburgh University. This one is from Edinburgh University. Prostate Cancer can have a psychological impact such as fear the cancer may recur, distress and lower quality of life. We are interested in how different people experience and cope with these impacts.
Tackle has been asked to contact their members about the opportunity to participate in two surveys. Tackle always look carefully at the many requests we receive to engage with our member groups. These two are of particular interest, one from Prostate Cancer UK and one from Edinburgh University. This one is from Prostate Cancer UK. Prostate Cancer UK recently launched a vital piece of work on active surveillance for men with localised prostate cancer. Active surveillance is a way of carefully monitoring prostate cancer that hasn't spread outside the prostate (localised prostate cancer), rather than treating it straight away with surgery or radiotherapy, for example.
Sainsbury's have invited our group to run an Awareness Day at their store in Nantwich for the day on Sunday 10th September. The invitation was accepted and there will be a stand in the store between 10:00 and 16:00 when we will be handing out leaflets and talking to the public.The stand is being manned by committee members on a rota basis and we hope to use the opportunity to raise awareness of the disease in the area.
Beechwood Cancer Care are running a day specifically designed to support men with a diagnosis of cancer. Date: Friday, September 1, 2017
To book contact: Deputy Clinical Manager; Colette Kelly (details below)
With thanks & Kind regards,
Deputy Clinical Manager
T: 0161 476 0384
F: 0161 477 5306
According to results from the Cancer Research UK-funded STAMPEDE clinical trial, offering abiraterone plus prednisolone in combination with standard therapy to men with prostate cancer earlier, before the disease becomes resistant to standard hormone therapy, can help boost survival. Click the following link to read the rest of the article on the Cancer Research Blog http://scienceblog.cancerresearchuk.org/2017/06/06/once-in-a-career-feeling-as-trial-shows-offering-prostate-cancer-drug-earlier-improves-survival/?utm_campaign=bl_AugustEnews_030817_ccmpe&utm_source=ccmp&utm_medium=email&cid=61844&mid=150711173
This is a story that appeared last month on the BBC News website at http://www.bbc.co.uk/news/av/magazine-40575149/cancer-mot-mechanic-taking-on-prostate-cancer
There is a video of Errol McKellar, a mechanic from Hackney who, after being diagnosed with prostate cancer in 2010, made it his mission to raise awareness of the condition by offering 20% discounts to any customer willing to go for cancer checks.
The results of the NHS England's annual survey of cancer patients were published last week, which we've revealed show a worrying decline in the number of men who say they were offered a specialist nurse to help them through their treatment. We also find out if there's any truth in recent media reports that tall men are at great risk of prostate cancer, and hear how a former 70s pub rock legend has taken to the stage again to raise money for us after his treatment for the disease. Plus, there's news of how you can volunteer for us and the latest issue of Insights magazine.
Barts Hospital London are currently running a Prostate Cancer clinical trial looking at how to stop low and intermediate prostate cancer from developing into high risk cancer. The PROVENT study is a clinical trial for men diagnosed with prostate cancer who are on active surveillance. It aims to test whether Aspirin and/or Vitamin D3 have the potential to stop low and intermediate risk prostate cancers from developing into high risk cancers. Homerton University Hospital, University College London Hospital, St Bartholomew’s Hospital and University Hospital Coventry are all currently recruiting participants to the study.